Request Demo
Last update 01 Mar 2025
PEGylated Recombinant Human Coagulation Factor VIII Fc Fusion Protein (Jiangsu Gensciences)
Last update 01 Mar 2025
Overview
Basic Info
Drug Type Recombinant coagulation factor, Antibody fusion proteins |
Synonyms FRSW 117, FRSW-117, FRSW117 |
Target |
Mechanism F10 stimulants(Coagulation factor X stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
RegulationOrphan Drug (US) |
Login to view timeline
Related
7
Clinical Trials associated with PEGylated Recombinant Human Coagulation Factor VIII Fc Fusion Protein (Jiangsu Gensciences)NCT06142552
Multicenter Study to Evaluate the Efficacy, Safety, Immunogenicity, and Pharmacokinetics of Recombinant Human Coagulation Factor Ⅷ-Fc Fusion Protein (FRSW117) for Injection in Patients With Severe Hemophilia A (Adults and Adolescents)
CTR20233517
评价注射用培重组人凝血因子Ⅷ-Fc融合蛋白（FRSW117）在经治重型血友病A患者（成人及青少年）中的有效性、安全性、免疫原性和药代动力学的开放、多中心Ⅲ期临床研究
[Translation] An open, multicenter phase III clinical study to evaluate the efficacy, safety, immunogenicity and pharmacokinetics of recombinant human coagulation factor VIII-Fc fusion protein for injection (FRSW117) in patients with severe hemophilia A (adults and adolescents) who have been treated
NCT05265286
A Phase II, Multicentre, Open-label Study to Evaluate the Pharmacokinetic, Safety and Preliminary Efficacy of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Subjects With Severe Hemophilia A
100 Clinical Results associated with PEGylated Recombinant Human Coagulation Factor VIII Fc Fusion Protein (Jiangsu Gensciences)
Login to view more data
100 Translational Medicine associated with PEGylated Recombinant Human Coagulation Factor VIII Fc Fusion Protein (Jiangsu Gensciences)
Login to view more data
100 Patents (Medical) associated with PEGylated Recombinant Human Coagulation Factor VIII Fc Fusion Protein (Jiangsu Gensciences)
Login to view more data
100 Deals associated with PEGylated Recombinant Human Coagulation Factor VIII Fc Fusion Protein (Jiangsu Gensciences)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hemophilia A | Phase 3 | CN | 27 Dec 2023 | |
| Hemorrhage | Phase 3 | CN | 27 Dec 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2 | 15 | wzrodntehv(tcwxvjtsyn) = edymyhumvf hnszvfocvo (lqjfoeldmm ) View more | - | 10 Dec 2023 | |||
wzrodntehv(tcwxvjtsyn) = duqeldkgxc hnszvfocvo (lqjfoeldmm ) View more | |||||||
Phase 1 | 13 | sxwdrweuci(viispygwxj) = cmdtowzbld gjkhbhudxu (vlqbjecbmx ) | - | 08 Jun 2023 | |||
sxwdrweuci(viispygwxj) = nsioeccyfe gjkhbhudxu (vlqbjecbmx ) |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free